General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Merck(SIGNIFICANT), Bayer(SIGNIFICANT), Boehringer Ingelheim(MODEST), Novo Nordisk Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Merck (SIGNIFICANT), Bayer(SIGNIFICANT), CSL Limited(SIGNIFICANT), Boehringer Ingelheim(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT)